Lantheus Holdings, Inc. has grown revenue 15% a year over three years and 35% a year over five, with earnings per share compounding at 104%. Revenue growth, 3-year annual rate: +15% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +35%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +104%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 13, FY2013 to FY2025, as filed.

LNTHLantheus Holdings, Inc.

HealthcareUSD

$100.82

$50.1152 weeks$109.01

Is it growing?

Is LNTH growing?

Lantheus Holdings, Inc. has grown revenue 15% a year over three years and 35% a year over five, with earnings per share compounding at 104%.

+15%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +35%
Revenue growth, 5-year rate · +15% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +104%
Earnings per share, 3-year rate · revenue +15% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed